Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

FENS 2020 | Early detection and new biomarkers for Alzheimer’s disease

Ioannis Sotiropoulos, PhD, Medical School, University of Minho, Braga, Portugal, highlights the focus of recent clinical trials in the early phases of Alzheimer’s disease and the importance of early diagnosis and prognosis based on peripheral biomarkers, such as exosomes in the blood. Additionally, Dr Sotiropoulos discusses precision medicine. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.